Press Releases
Broadcom Inc. to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on Wednesday, December 9, 2026
PALO ALTO, Calif., Nov. 9, 2026 /PRNewswire/ -- Broadcom Inc. (NASDAQ: AVGO), a global technology leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced it will report its fourth quarter and fiscal year 2026 financial results and business outlook on Wednesday, December 9, 2026 after the close of the U.S. trading session...
Allogene Therapeutics Reports First Clinical Data from Phase 1 RESOLUTION Study of ALLO-329 in Autoimmune Disease
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today announced preliminary safety, efficacy and translational data from the ongoing Phase 1 RESOLUTION study evaluating ALLO-329, an investigational, next-generation, off-the-shelf allogeneic CAR T product designed specifically for autoimmune disease. The data are being presented today at the American College of Rheumatology (ACR) Convergence in Orlando, Florida...
Lazard Asset Management Launches Its First Three Fixed Income ETFs, Providing Investors New Ways to Access Differentiated Income
New actively managed ETFs provide access to Lazard's specialized expertise across US high yield, financial hybrids, and non-dollar bond opportunities NEW YORK, Nov. 9, 2026 /PRNewswire/ -- Lazard Asset Management ("LAM") today announced its entry into fixed income ETFs with the launch of three actively managed strategies: Lazard US High Yield ETF (NYSE Arca: HYB), Lazard Hybrid Financial Income ETF (NYSE Arca: HYFY), and Lazard Non-Dollar Active Income ETF (NYSE Arca: XDLR). Each is managed by a specialized Lazard investment team and designed to give investors differentiated sources of income...
Kratos Awarded Contract to Deliver Fully Integrated Q/V/Ka-Band Gateway and Antenna Systems for Gulf Space Technology's Software-Defined Satellite
Turnkey high-capacity gateway infrastructure with integrated monitoring and control complements Kratos' ongoing development of Gulf Space Technology's Satellite Operations Center Turnkey high-capacity gateway infrastructure with integrated monitoring and control complements Kratos' ongoing development of Gulf Space Technology's Satellite Operations Center
Whitehawk Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights
On track to report initial Phase 1 data from HWK-007 and HWK-016 in 1H'27 Initiated Phase 1 trial for HWK-206 in the U.S., the third Whitehawk program to enter the clinic in the last 12 months; HWK-206 received Fast Track designation from the FDA Cash, cash equivalents and short-term investments of $169.7 million as of September 30, 2026, anticipated to fund operations into 2H 2028 MORRISTOWN, N.J., Nov. 9, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently develop improved antibody drug conjugate (ADC) cancer treatments, today announced financial results for the quarter ended September 30, 2026, and provided recent corporate highlights...
red violet to Participate in the 7th Annual Needham Virtual Tech Week
BOCA RATON, Fla., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading identity intelligence and analytics company, today announced that it will participate in the 7th Annual Needham Virtual Tech Week being held November 18-20, 2026. Derek Dubner, Chief Executive Officer, and Dan MacLachlan, Chief Financial Officer, will host investor meetings on November 18, 2026...
Alkami to Present at Stephens Annual Investment Conference | NASH2026
PLANO, Texas, Nov. 9, 2026 /PRNewswire/ -- Alkami Technology, Inc. (Nasdaq: ALKT) ("Alkami"), a digital sales and service platform provider for financial institutions in the U.S., today announced that company executive leadership will present at the 2026 Stephens Annual Investment Conference | NASH2026 on Tuesday, November 17, 2026. Cassandra Hudson, chief financial officer, will be presenting...
Monopar Presents Data Highlighting Residual Disease Burden in Treatment-Experienced Wilson Disease Patients and Long-Term Molybdenum Safety Data for ALXN1840 at AASLD – The Liver Meeting® 2026
WILMETTE, Ill., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced the presentation of baseline data from the Phase 3 FoCus trial characterizing residual disease burden in treatment-experienced patients with Wilson disease, along with molybdenum balance and long-term uric acid data for ALXN1840 (tiomolibdate choline, TMC), the Company's investigational therapy for Wilson disease, at the American Association for the Study of Liver Diseases (AASLD) – The Liver Meeting 2026, held Nov. 5–9, 2026, in Denver, Colorado...
American Fusion Inc. (OTCQB: AMFN) Announces Independent Third-Party Texatron™ Technology Review and Anticipated North Texas Ranch Facility Acquisition
SOUTHLAKE, Texas, Nov. 09, 2026 (GLOBE NEWSWIRE) -- American Fusion Inc. (OTCQB: AMFN) (“American Fusion” or the “Company”), developer of the proprietary Texatron™ Fusion Engine™, today announced two developments in the advancement of its fusion technology program and North Texas research and development infrastructure. Independent Third-Party Technology Review Underway American Fusion is currently undergoing an independent third-party technology review of its proprietary Texatron™ fusion energy platform...
CLEAR Offers Secure Identity in Epic for Community Provider Access and Controlled-Substance Prescribing
CLEAR1 in Epic Toolbox now helps health systems verify outside providers and prescribing clinicians NEW YORK, Nov. 9, 2026 /PRNewswire/ -- CLEAR (NYSE: YOU), the secure identity company, today announced that CLEAR1, CLEAR's secure identity platform, is live in two new integrations in Epic Toolbox. One is for EpicCare Link, the portal community providers use to reach a health system's patient records, and the other is for electronic prescribing of controlled substances (EPCS)...
Edgewise Therapeutics to Participate in Upcoming Investor Conferences
BOULDER, Colo., Nov. 9, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading clinical-stage cardiovascular biopharmaceutical company, today announced that management will participate in the following investor conferences: Guggenheim 3rd Annual Healthcare Innovation Conference Fireside chat: Tuesday, November 10, 2026 at 8:00 am ET 2026 Truist Biopharma Symposium Fireside chat: Thursday, November 12, 2026 at 10:30 am ET The webcasts can be found on the Edgewise Events & Presentations page and will be accessible for replay, for a limited time, following the conference...
BioVie Presents New Biomarker Data from the ADDRESS-LC Trial of Bezisterim in Long COVID at the NIH RECOVER-TLC Third Annual Workshop
New findings from the Phase 2 ADDRESS-LC trial suggest two distinct biomarker-defined Long COVID endotypes 1 associated with different patient responses to bezisterim treatment. Patients with a high-inflammatory endotype showed improvements in objective cognitive impairment, while those with a low-myeloid endotype experienced improvements in fatigue and post-exertional malaise...
Intuitive Machines Selected for NASA's Next-Generation Lunar Delivery Contract to Support Moon Base
HOUSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines,” together with its subsidiaries, the “Company”), a leading space infrastructure company, today announced it has been selected by NASA for its next-generation Commercial Lunar Payload Services 2 (CLPS 2) contract. CLPS 2 significantly expands the services NASA can procure, including complete payload delivery missions, direct lander acquisitions, and funded technology and payload development...
Viasat Awarded Phase 1 Contract Under NASA NEXUS Initiative
CARLSBAD, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications and networking technologies, today announced it has been selected by NASA for phase 1 of its Network Extension for User Continuity and Sustainability (NEXUS) initiative, awarded through the Next Space Technologies for Exploration Partnerships-3 (NextSTEP-3) Omnibus Broad Agency Announcement...
Royal Bank of Canada announces agreement to acquire Yarra Capital Management
Acquisition will serve as a springboard for RBC Global Asset Management's growth ambitions and commitment to the Australian investment management market TORONTO, Nov. 9, 2026 /PRNewswire/ -- Royal Bank of Canada (RBC) (TSX: RY) (NYSE: RY) today announced it has entered into an agreement to acquire Yarra Capital Management Limited (Yarra), an award-winning1 active asset manager that specializes in Australian fixed income, Australian equities and alternative investment solutions. Yarra, founded in 2017, with offices in Melbourne and Sydney, has approximately A$18 billion in assets under management as at September 30, 2026, and approximately 75 employees...
Tectonic Therapeutic to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will participate in fireside chats at the upcoming Stifel 2026 Healthcare Conference, and the Piper Sandler 38th Annual Healthcare Conference...
Eos SENOLYTIX's PTC-2105 Reduced Semaglutide-Associated Lean-Mass Loss in Aged Mice: Data to Be Presented at 19th Sarcopenia, Cachexia & Wasting Disorders International Conference
Data to highlight PTC-2105's attenuation of terminal lean-mass decline and semaglutide-associated lean-mass loss in aged mice PTC-2105 is Eos's lead clinical candidate in development for elderly patients with Sarcopenia and Sarcopenic Obesity Eos's merger with Pulmatrix, Inc. anticipated to close in Q4 2026, subject to Nasdaq listing approval and customary closing conditions HOUSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Eos SENOLYTIX, Inc. (“Eos” or the “Company”), a biotechnology company developing mitochondria-targeted geropeptides to improve healthspan, today announced it will present new data from a pre-clinical study of its lead MitoXcel™ geropeptide, PTC-2105, at the 19th Sarcopenia, Cachexia & Wasting Disorders International Conference (SCWD), taking place December 10-12, 2026 in Washington, D.C. Eos's presentation was recently upgraded from a poster presentation to a plenary presentation in the Rapid Fire Abstract Session to be held on December 11, 2026, at 9:35 am...
Actinium Pharmaceuticals Announces Formation of Scientific Advisory Board Featuring Leading Experts in Oncology and Radiopharmaceutical Development
Scientific Advisory Board brings together world-class expertise in prostate cancer, hematologic malignancies, molecular imaging, radiochemistry and clinical development Internationally recognized advisers to support advancement of Actinium's differentiated radioconjugate pipeline across solid tumors and hematologic malignancies NEW YORK, Nov. 9, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or the "Company"), a pioneer in the development of targeted radiotherapies, today announced the formation of a Scientific Advisory Board comprising five distinguished clinicians and scientists with extensive experience in oncology, nuclear medicine and radiopharmaceutical development. The Scientific Advisory Board will provide strategic scientific and clinical guidance to support the advancement of Actinium's differentiated radioconjugate pipeline, including ATNM-400, its HER3-targeted alpha radiotherapy currently in a first-in-human Phase 1 study in metastatic castration-resistant prostate cancer...
OneMedNet Partners to Combine First-Party Multimodal Clinical Data with Comprehensive Patient-Journey AI Analytics, Expanding Commercial Reach Through 13th Channel Partnership
MINNEAPOLIS, Nov. 09, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced its 13th channel partner agreement. Under the agreement, an AI-powered healthcare intelligence company will re-sell OneMedNet's U.S.-sourced, de-identified multimodal clinical data in combination with its own comprehensive real-world patient journey assets...
OSS Awarded $2.75 Million Contract by U.S. Army to Develop Next-Generation Compute Appliance for Tactical Ground Vehicles
Strengthens OSS's role in developing the U.S. Army's next-generation tactical ground vehicle compute architecture Advanced compute system designed to support operational C5ISR integration and distribution Development award may provide opportunities for future production programs across multiple U.S. Army and allied vehicle platforms ESCONDIDO, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced it has been awarded a $2.75 million contract by the U.S. Army to develop a next-generation compute appliance for tactical ground vehicles...
Walmart, Sam's Club and The Salvation Army Make It Easy to Support Families in Need This Christmas
The Salvation Army Angel Tree, Red Kettles, volunteer opportunities and online giving offer Walmart customers and Sam's Club members multiple ways to spread hope and give back this holiday season ALEXANDRIA, Va., Nov. 9, 2026 /PRNewswire/ -- For more than forty years, Walmart, Sam's Club and The Salvation Army have worked together to help individuals and families facing hardship find support, encouragement and hope during the Christmas season and throughout the year...
RTX's Raytheon advances Joint Reduced Range Rocket with third successful flight test
Reusable pod and affordable training round demonstrated for the U.S. Army TUCSON, Ariz., Nov. 9, 2026 /PRNewswire/ -- Raytheon, an RTX (NYSE: RTX) business, demonstrated its DeepStrikeTM JR3 solution for the U.S. Army's Joint Reduced Range Rocket program during a third successful flight test.
Harmonic to Participate in 7th Annual Needham Virtual Tech Week Conference
SAN JOSE, Calif., Nov. 9, 2026 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced that Nimrod Ben-Natan, President and Chief Executive Officer of Harmonic, and Walter Jankovic, Chief Financial Officer, will host investor meetings at the 7th Annual Needham Virtual Tech Week Conference on Wednesday, November 18, 2026...
WhiteHorse Finance, Inc. Announces Third Quarter 2026 Earnings Results and Declares Quarterly Distribution of $0.25 Per Share
NEW YORK, Nov. 9, 2026 /PRNewswire/ -- WhiteHorse Finance, Inc. ("WhiteHorse Finance" or the "Company") (Nasdaq: WHF) today announced its financial results for the third quarter ended September 30, 2026. In addition, the Company's board of directors has declared a distribution of $0.25 per share with respect to the quarter ending December 31, 2026...
Greene County Bancorp, Inc. Announces Name Change to Greene Bancorp, Inc.
CATSKILL, N.Y., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Greene County Bancorp, Inc. (Nasdaq: GCBC) (the “Company”) today announced that its stockholders approved an amendment to the Company's Charter changing the Company's legal name to Greene Bancorp, Inc. at the Annual Meeting of Stockholders held on November 7, 2026...
Owlting Group (NASDAQ: OWLS) Secures Additional US$5 Million Financing from The Lind Partners
ARLINGTON, Va., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Owlting Group (NASDAQ: OWLS) (“Owlting” or the “Company”), the operating brand of OBOOK Holdings Inc., a global fintech company building regulated payment infrastructure, today announced the closing of a US$5 million follow-on financing with Lind Global Asset Management XV LLC (“Lind”), an investment fund managed by The Lind Partners...
ASML reports transactions under its current share buyback program
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program.
Evaxion files amendment to registration statement related to 2025 EIB debt settlement agreement
COPENHAGEN, Denmark, November 9, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, has filed an amendment to its registration statement on Form F-1 related to the 2025 debt settlement agreement with The European Investment Bank (EIB) with the US Securities and Exchange Commission...
STMicroelectronics announces status of common share repurchase program
STMicroelectronics announces status of common share repurchase program Disclosure of Transactions in Own Shares – Period from November 2, 2026 to November 6, 2026 AMSTERDAM – November 9, 2026 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full details of its common share repurchase program (the “Program”) disclosed via a press release dated June 21, 2024...
KALA BIO Provides CEO Update and Preliminary Third Quarter 2026 Financial Results
New York, New York--(Newsfile Corp. - November 9, 2026) - KALA BIO, Inc. (NASDAQ: KALA) today announced preliminary unaudited financial results for the quarter ended September 30, 2026. Preliminary Third Quarter 2026 Results Net loss of approximately $0.8 million for the third quarter of 2026, compared to $7.6 million for the third quarter of 2025...
QSE Expands UK Market Presence Through Strategic Defence, Government and Financial Sector Engagements
Company showcased QPrime and QREK as regulated industries prepare for a multi-year cybersecurity transition Vancouver, British Columbia--(Newsfile Corp. - November 9, 2026) - Quantum Secure Encryption Corp. (CSE: QSE) (OTCQB: QSEGF) (FSE: VN80) ("QSE" or the "Company"), a Canadian developer of post-quantum cybersecurity solutions, announces that it participated in a coordinated programme of UK government and industry engagements following an invitation from Quantum North. The programme connected QSE with defence, financial services and cybersecurity stakeholders, providing opportunities to demonstrate its technology and explore potential technical evaluations and integration partnerships in highly regulated markets...
Quarterhill Selected by Idaho Transportation Department to Support and Modernize Commercial Vehicle Screening Infrastructure
Agreement builds on long-standing partnership and supports critical weigh-in-motion, electronic screening, and commercial vehicle enforcement systems across Idaho TORONTO, Nov. 9, 2026 /PRNewswire/ -- Quarterhill Inc. ("Quarterhill" or the "Company") (TSX: QTRH) (OTCQX: QTRHF), a leading technology innovator providing next-generation, AI-driven Intelligent Transportation System ("ITS") solutions, today announced it has been awarded a contract valued at approximately $1.78 million USD by the Idaho Transportation Department ("ITD") to maintain, support and modernize the state's commercial vehicle operations and screening infrastructure. The contract has an initial one-year term that began Oct. 1, 2026, and includes an option for an additional one-year extension by mutual agreement...
Railtown AI Expands Apple Developer Ecosystem with Open-Source Swift Framework for Private On-Device AI Agents and Local Knowledge Bases
Railtracks Swift enables developers to build privacy-focused AI applications using Apple's on-device intelligence, searchable Knowledge Bases and Siri-enabled experiences, while expanding Railtown's global developer ecosystem. Vancouver, British Columbia--(Newsfile Corp. - November 9, 2026) - Railtown AI Technologies Inc. (CSE: RAIL) (OTCQB: RLAIF) ("Railtown" or the "Company") is pleased to announce the availability of local Knowledge Base and on-device artificial intelligence capabilities through Railtracks Swift RAG, an open-source library within the Company's Railtracks Swift Agent Development Kit (ADK)...
Adia Med CEO Larry Powalisz Issues Open Letter on Leadership Journey, Research Mission, and Progress Since 2024
Winter Park, Florida--(Newsfile Corp. - November 9, 2026) - Adia Med Inc. (OTCQB: ADIA) today released the following open letter from Chief Executive Officer Larry Powalisz outlining the company's progress since the January 2024 leadership transition, its regenerative medicine research mission, and efforts to generate evidence that could support broader access to investigational therapies. An Open Letter from Larry Powalisz, CEO of Adia Med Inc. November 5, 2026Winter Park, Florida To Our Stakeholders, Patients, Physicians, and Friends: When I became CEO of what was then Adia Nutrition Inc. in January 2024, the company was largely inactive...
Shoppers Are Making Their Lists and Checking Their Favorite Retailers First
Key Highlights New Synchrony research finds 83% of consumers agree they plan to do most of their holiday shopping with retailers they know and trust 66% of consumers agree they plan to use retailer rewards they've earned this holiday season, up 13 percentage points from 2025 28% of consumers are taking a more selective approach to holiday spending with what and where they buy STAMFORD, Conn., Nov. 9, 2026 /PRNewswire/ -- Holiday shoppers are making their lists, and familiar retailers are getting the first look...
Pacific Booker Minerals Inc. Announces Closing of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - November 9, 2026) - Pacific Booker Minerals Inc. (TSXV: BKM) (OTC Pink: PBMLF) ("Pacific Booker" or the "Company") today announced the closing of its previously announced upsized non-brokered private placement (the "Private Placement"), subject to final TSX Venture Exchange approval, raising gross proceeds of $12,000,002.04 through the issuance of 5,128,206 units ("Units") at a price of $2.34 per Unit. Each Unit consists of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant")...
AMD EPYC Expands Its Leadership at the Foundation of AI
5th Gen AMD EPYC processors power Google Cloud TPU 8tx host infrastructure, helping enterprises protect sensitive AI models 5th Gen AMD EPYC processors power Google Cloud TPU 8tx host infrastructure, helping enterprises protect sensitive AI models
Abundia Global Impact Group Provides Third Quarter 2026 Business Update
RPD Technologies segment revenue up 65% year-over-year to $2.2 million in the third quarter W aste-to-fuels commercialization milestones remain on schedule HOUSTON, TX, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Abundia Global Impact Group, Inc. (NYSE American: AGIG) (“Abundia” or the “Company”), today provided a business update following the release of its financial results for the third quarter ended September 30, 2026, highlighting continued revenue growth, disciplined capital allocation and on-schedule execution of its waste-to-fuels commercialization strategy. “The third quarter reflects continued execution of our waste-to-fuels commercial strategy,” said Ed Gillespie, Chief Executive Officer of Abundia...
Enerpac Tool Group To Present At The Baird Global Industrial Conference
MILWAUKEE, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Enerpac Tool Group Corp. (NYSE: EPAC) (“Enerpac” or the “Company”) will present at the Baird Global Industrial Conference in Chicago on Tuesday, November 10, 2026. Paul Sternlieb, President and Chief Executive Officer, and Darren Kozik, Executive Vice President and Chief Financial Officer, are scheduled to present at 10:15 a.m. CT. Accompanying materials will be made available on the Company's website, ir.enerpactoolgroup.com, prior to the presentation...
Whirlpool Corporation Celebrates 115th Anniversary, Reaffirming Commitment to Improving Life at Home
The only major American-owned kitchen and laundry appliance manufacturer celebrates 115 years by awarding 115 new appliances to families across the U.S. BENTON HARBOR, Mich., Nov. 9, 2026 /PRNewswire/ -- Whirlpool Corporation (NYSE: WHR) today celebrates 115 years of improving life at home.
Salvatore Abbate to Assume Role of LKQ President and CEO on November 9, 2026
ANTIOCH, Tenn., Nov. 09, 2026 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) today announced that Salvatore A. “Sal” Abbate will assume the role of President and Chief Executive Officer and join the Company's Board of Directors effective November 9, 2026, ahead of the previously announced start date of December 15, 2026...
AEON Biopharma Submits IND for Comparative Pharmacodynamic Study of ABP-450
Submission advances ABP-450 biosimilar development program following recent FDA Type 2b meeting
Iambic to participate in Jefferies Global Healthcare Conference
Co-Founder and CEO Tom Miller joins AI drug discovery panel on November 18, 2026 Co-Founder and CEO Tom Miller joins AI drug discovery panel on November 18, 2026
ADARx Pharmaceuticals to Present at the UBS Global Biopharma Conference
SAN DIEGO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (Nasdaq: ADRX), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, today announced that Zhen Li, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the UBS Global Biopharma Conference in London, UK on Monday, November 16, at 2:00 p.m...
Lincoln Educational Services Reports Strong Third Quarter Financial Results, Student Starts Increase More Than 14%, Adjusted EBITDA Grows Nearly 31%
PARSIPPANY, N.J., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) today reported financial results for the third quarter and nine months ended September 30, 2026, as well as recent business developments.
Tristan Harding Joins Beacon Trust as Managing Director, Head of Relationship Management and Growth
ISELIN, N.J., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Beacon Trust , a wholly owned subsidiary of Provident Bank, announced today that Tristan Harding has joined the company as Managing Director, Head of Relationship Management and Growth.
Enphase Energy Announces More Than 8 Million IQ Microinverters and Nearly 500 MWh of IQ Batteries Have Shipped from U.S. Manufacturing Facilities
FREMONT, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced it has shipped more than eight million IQ Microinverters and nearly 500 MWh of IQ Batteries from U.S. contract manufacturing facilities...
DeFi Development Corp. Increases SOL Treasury to 2.61 Million
Company Adds 8,881 SOL and SOL Equivalents, Marking Nine Consecutive Weeks of SOL Purchases CHAD's 14.00% annual dividend rate continues to offer one of the most competitive income opportunities in digital credit BOCA RATON, FL, Nov. 09, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the "Company" or "DeFi Dev Corp."), the first U.S. public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced that its total holdings of SOL and SOL equivalents increased by 8,881 SOL since its last update, bringing its treasury to approximately 2,609,829 SOL, up from 2,600,948 SOL. The increase marks the Company's ninth consecutive week of SOL purchases since September 14, 2026, building on its return to active accumulation on August 27...
Mereo BioPharma Reports Third Quarter 2026 Financial Results
Ongoing regulatory interactions in collaboration with Ultragenyx on potential path forward for setrusumab in osteogenesis imperfecta (OI) Ongoing FDA interactions in collaboration with Sentynl Therapeutics to refine Phase 3 trial design for alvelestat in alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD) Cash and cash equivalents of $26.1 million at September 30, 2026, expected to fund operations into late-2027 LONDON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced financial results for the third quarter ended September 30, 2026, and provided an update on its late-stage programs. “During the third quarter, we have made meaningful progress on our two core programs, setrusumab and alvelestat...
Xcel Brands Announces Exploration of Strategic Alternatives for Non-Core Legacy Assets to Optimize Balance Sheet
NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (NASDAQ: XELB) ("Xcel" or the "Company"), a leading media and consumer products company specializing in creator or influencer-led brands, social commerce, and livestream shopping, today announced that its Board of Directors has initiated a process to explore strategic alternatives for certain of its non-core legacy assets. The strategic initiative aims to streamline the Company's operational focus while strengthening its balance sheet...
Sonoco Announces CEO Succession Plan
Howard Coker to Retire Following Distinguished 41-year Career, Including as Director, President and CEO since 2020 Ernest Haynes, Sonoco President of Global Consumer Packaging to Succeed Coker as Director, President and CEO HARTSVILLE, S.C., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a Mid-cap Value global packaging company, today announced that R...
Achieve Life Sciences Becomes AchieveRx, The Quit Company, and Will Trade Under the Ticker QUIT
SEATTLE and VANCOUVER, British Columbia, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) today announced that it has rebranded and will now be doing business as AchieveRx™, The Quit Company™ (AchieveRx or the Company), a late-stage pharmaceutical company focused on nicotine dependence. The Company's common stock is expected to begin trading on Nasdaq under the new ticker symbol QUIT on November 10, 2026...
MindWave Innovations Inc. USA and Skalup Capital Singapore Form Bermuda Insurance Joint Venture, Pursue Insurance License with Bermuda Monetary Authority
Joint venture pairs MindWave's blockchain infrastructure and digital-asset-backed capital, in the form of staking, with Skalup's insurance expertise to build reinsurance capacity in one of the world's leading insurance markets MATAWAN, N.J., Nov. 09, 2026 (GLOBE NEWSWIRE) -- via IBN — MindWave Innovations Inc. USA (“MindWave”), a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), has entered into a Shareholders' and Joint Venture Agreement with Singapore-based Skalup Capital Pte Ltd (“Skalup”) to establish an insurance and technology business in Bermuda under the working brand Monaco Insurance, subject to final regulatory approval...
Amarin Highlights New Data on Lipoprotein(a) and other Apolipoprotein B Containing Lipoproteins at American Heart Association (AHA) Scientific Sessions 2026
DUBLIN and BRIDGEWATER, N.J., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease worldwide, today highlighted new clinical data evaluating lipoprotein(a) [Lp(a)] and other apolipoprotein B (apoB) containing lipoproteins as predictors of major adverse cardiovascular events (MACE), as well as new mechanistic findings examining the effects of eicosapentaenoic acid (EPA) on Lp(a) oxidation and related inflammatory and oxidative stress pathways...
Humacyte Highlights First-in-Human Coronary Bypass Study at American Heart Association Scientific Sessions 2026
– Humacyte has initiated the CABG clinical study and looks forward to the commencement of screening for potential patients. – “Moving it into a first-in-human study is the step that will tell us whether an off-the-shelf conduit can perform in the coronary position,” says cardiothoracic surgeon Alan Kypson, M.D...
Sharplink Reports Third Quarter 2026 Financial and Operating Results
Strong Financial Performance Reflects Continued Execution of Active Treasury Management and Disciplined Capital Allocation Revenue up 24% YoY to $13.5 Million; Net Income of $751.4 Million or $3.45 Per Diluted Share MIAMI, FL, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Sharplink, Inc. (Nasdaq: SBET) (“Sharplink” or the “Company”), one of the world's largest corporate holders of Ether (“ETH”) and prominent industry advocate of Ethereum adoption, today reported financial and operating results for the three and nine months ended September 30, 2026, along with an update on its ETH treasury strategy. “Our strong third quarter performance reflects our progress in executing our Ethereum treasury strategy and further strengthening our institutional-grade treasury platform,” said Joseph Chalom, Chief Executive Officer of Sharplink...
Quanome Enters into Agreement for Strategic Investment in QAI Labs, Advancing Quantum Life Sciences Strategy
All-stock transactions will give Quanome approximately 5% stake in QAI Labs, the developer of NOVA-3, an AI-enabled platform designed for multi-specific antibody discovery New York, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Quanome Technologies, Inc. (Nasdaq: QNME) ("Quanome" or the "Company") today announced that it has entered into a definitive agreement, dated November 4, 2026, for its strategic investment in QAI Labs Ltd. ("QAI Labs" or "QAI"), an early-stage life sciences technology company developing NOVA-3, an AI-enabled discovery platform designed to combine quantum-computing algorithms (run on classical simulators) with laboratory testing to advance multi-specific antibody candidates...
Jasper Therapeutics, Inc. Announces Results of the Offer to Purchase Relating to Its Warrants
REDWOOD CITY, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper” or the “Company”), a clinical stage biotechnology company focused on the design and development of innovative therapies to treat immune-mediated diseases, today announced the results of its offer to purchase (the “Offer”) all of its outstanding warrants to purchase shares of its common stock, par value $0.0001, which were issued and sold as part of an underwritten public offering on September 18, 2025 (the “Warrants”) at a purchase price of $0.324 in cash per Warrant, without interest, which expired at 12:00 a.m...
Prime Medicine to Present at Jefferies Global Healthcare Conference
CAMBRIDGE, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that Allan Reine, M.D.
Global Ship Lease Reports Results for the Third Quarter of 2026
Annualized dividend to increase to $2.75 per Class A Common Share Further de-risked our newbuilding program with $1.0 billion credit facility 100% contract cover for 2026, 98% for 2027, and 74% for 2028 ATHENS, Greece, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE: GSL) (the “Company”, “Global Ship Lease” or “GSL”), an owner of containerships, announced today its unaudited results for the three and nine-month periods ended September 30, 2026. Third Quarter of 2026 and Year to Date Highlights and Other Recent Developments - 3Q 2026 operating revenue of $201.4 million...
Compass Therapeutics Reports 2026 Third Quarter Financial Results and Provides Corporate Update
Compass is advancing preparations for a BLA submission for tovecimig in patients with BTC and plans to further engage with the FDA. Data from the COMPANION-002 study of tovecimig, including newly disclosed durability of response and crossover-adjusted OS analyses, were published in the Journal of Clinical Oncology and presented at the 2026 ESMO Congress in October...
CC Shareholders Have Rights – If You Lost Money Investing in The Chemours Company Contact Robbins LLP About Recovering Your Losses
SAN DIEGO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquired The Chemours Company (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours offers a range of industrial and specialty chemical products for markets including, as relevant here, refrigeration and air conditioning...
HyOrc Advances Commercial Waste-to-Syngas Project in India Following Government Approval
HOUSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- HyOrc Corporation (OTCQB: HYOR) announced that Tamil Nadu's District Rural Development Agency (DRDA) approved HyOrc India's project report for a proposed 10 TPD waste-to-syngas facility in Kanyakumari District and identified land for implementation, advancing plans for industrial syngas sales under a proposed long-term public-private partnership. Project Highlights Government-approved project report and identified 2,023 m² site Initial capacity: 10 TPD RDF processing and projected 10 tonnes/day of hydrogen-rich syngas Estimated annual revenue of $562,000 and operating contribution of $211,000 at planned capacity Proposed minimum 10-year public-private partnership, with expansion opportunities The approval follows a September 2 inspection of HyOrc India's Pothayadi facility, where government officials reviewed its RDF-to-energy technology...
CHIPOTLE BRINGS BACK RECORD-BREAKING "TATTED LIKE A CHIPOTLE BAG" BOGO ON FRIDAY, NOVEMBER 13
Chipotle's Friday the 13th promotion returns Friday, November 13 with a one-hour flash BUY-ONE-GET-ONE (BOGO) entrée offer for tattooed guests from 3 to 4 p.m. local time at participating restaurants across the U.S. and Canada1 Chipotle superfan and multi-platinum selling, GRAMMY and Golden Globe nominated recording artist Wiz Khalifa is teaming up with the brand to co-create limited-edition to-go bags featuring designs inspired by his tattoos, available exclusively at a Chipotle restaurant in his hometown of Pittsburgh during the promotion2 NEWPORT BEACH, Calif...
Kaplan Fox Reminds O-I Glass, Inc. (OI) Investors with Significant Losses to Seek a Leadership Role Before Deadline on December 28, 2026
New York, New York--(Newsfile Corp. - November 9, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against O-I Glass, Inc. ("O-I Glass" or the "Company") (NYSE: OI) on behalf of investors that purchased or otherwise acquired O-I Glass common stock between March 14, 2025 and July 28, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in O-I Glass and have suffered losses, you may CLICK HERE to contact us...
RB Global Reports Third Quarter 2026 Results
WESTCHESTER, Ill.--(BUSINESS WIRE)--RB Global, Inc. (NYSE & TSX: RBA, the “Company”, “RB Global”, “we”, “us”, or “our”) reported the following results for the three months ended September 30, 2026. "Our third-quarter results demonstrate the strength of RB Global's marketplace and the consistent execution of our teams to deliver solid topline and bottom-line growth," said Jim Kessler, CEO of RB Global. “We remain committed to gaining market share, delivering strong growth across all our busi...
Sky Quarry Signs LOI with E2 Lab Services to Collaborate on PR Spring Facility
WOODS CROSS, Utah, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Sky Quarry Inc. (NASDAQ: SKYQ) (“Sky Quarry” or the “Company”), an energy infrastructure company focused on domestic refining and resource development, today announced that it has signed a non-binding letter of intent (“LOI”) with E2 Lab Services & Consulting LLC (“E2”) to evaluate and negotiate a potential strategic collaboration relating to the completion, commissioning and operational readiness of Sky Quarry's PR Spring facility in Utah. Under the proposed collaboration, which remains subject to definitive agreements, E2 would provide engineers, technical specialists and operational personnel to assist Sky Quarry's team in reviewing PR Spring's existing infrastructure and installed equipment, preparing a prioritized engineering and completion plan, developing production workflows and operating procedures, and supporting commissioning and the initial production ramp...
Abaxx Announces Conclusion of Independent Investigation; Findings Refute Short-Seller Allegations
Investigation's findings confirmed the Company's trading activity and market disclosures with respect to the allegations were accurate and compliant in all material respects. Insinuations that market-making incentive programs are inherently problematic distort their established and essential role in developing liquidity in new commodity futures markets...
Profound Medical to Participate in the Stifel 2026 Healthcare Conference
TORONTO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today announced that its President, Richard Fabian, will present at the Stifel 2026 Healthcare Conference on Thursday, November 12, 2026 at 8:40 a.m. Eastern Time in NYC...
Coincheck Reports Financial Results for Second Quarter of Year Ending March 31, 2027
AMSTERDAM--(BUSINESS WIRE)--Coincheck Group N.V. (NASDAQ: CNCK) (“Coincheck Group” or the “Company”), a Dutch public limited liability company that provides digital asset trade execution, custody, staking and asset management services, today reported financial results for the second quarter of the fiscal year ending March 31, 2027 (“fiscal 2027”). References to “fiscal 2026” mean the fiscal year ended March 31, 2026. Financial Highlights:1 Certain Year-Over-Year Highlights Total revenue for the...
Enough Is Enough: CTNT's Board Has Had Its Chance; Now Stockholders Deserve Theirs
Takeover Time Calls on Eligible CTNT Stockholders to Make Their Voices Heard Through the Green Consent Card Takeover Time Calls on Eligible CTNT Stockholders to Make Their Voices Heard Through the Green Consent Card
Rail Vision's Quantum Platform Launches End-to-End Quantum Error Correction Program at the Israeli Quantum Computing Center
Ra'anana, Israel, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN, FSE: C80) (“Rail Vision” or the “Company”), an early commercialization stage technology company transforming railway safety through advanced AI-integrated sensing systems, announces today, that its subsidiary Quantum Transportation Ltd. (“Quantum Transportation”) launched an end-to-end Quantum Error Correction (QEC) program on the Arbel superconducting quantum processor at the Israeli Quantum Computing Center (IQCC)...
GIX Internet Secures Follow-On Order from One of the Top Hospitals in the World to Double Its Robot Fleet
The order, received by Deliverz.AI, is for three additional autonomous robots and supports planned expansion into operating-room logistics and specimen collection across hospital departments
QumulusAI Secures a Contracted 1.2 MW of Colocation Capacity in Denver, Ready for Service by Q1 2027
ATLANTA--(BUSINESS WIRE)---- $QMLS #NASDAQ--QumulusAI (Nasdaq: QMLS), a neocloud infrastructure provider purpose-built for the AI computing era, today announced a five-year colocation agreement for a contracted 1.2 MW of critical IT load in Denver, with automatic five-year renewal terms. QumulusAI already operates in Denver, and the agreement expands its capacity in that market. The capacity is expected to be ready for service in Q1 2027, and the initial five-year term runs from the date the contracted services...
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to King's College London
Filament has shipped PEX010 to King's College London for SLEEPY, a feasibility study of giving psilocybin just before sleep. Toronto, Ontario--(Newsfile Corp. - November 9, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector...
Cognition Therapeutics Invited to Participate in 2026 Jefferies Global Healthcare Conference
PURCHASE, N.Y., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders (the “Company” or “Cognition”), announced that the Company's president and CEO, Lisa Ricciardi intends to participate in the 2026 Jefferies Global Healthcare Conference taking place November 16-19 in London, UK. The meeting is Europe's largest healthcare-dedicated financial conference, attracting an estimated 800 global public and private companies across the life sciences. During the meeting, Ms. Ricciardi will discuss the company's recent FDA meeting to finalize the selection of endpoints for the planned Phase 3 study of zervimesine in dementia with Lewy bodies (DLB). She will be available for one-on-one investor meetings throughout the conference and investors interested in arranging meetings should contact their Jefferies representative...
FTI Consulting Bolsters North American Telecom Practice With Appointment of Two Senior Managing Directors
Moe Kelley and Brian Bagenstose will support TMT and digital infrastructure operators and investors with growth strategy and commercial due diligence Moe Kelley and Brian Bagenstose will support TMT and digital infrastructure operators and investors with growth strategy and commercial due diligence
Cytokinetics Announces Additional Data Related to Aficamten Presented at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026
New Analyses Across Obstructive and Non-obstructive HCM Expand Clinical Evidence for Aficamten
PharmAla Biotech Signs Supply and Data Agreement with Aalborg University Hospital for Danish Randomized Trial of MDMA-Assisted Treatment for Service-Related PTSD
PharmAla signs a contract to provide MDMA to the University of Aalborg in exchange for cash and data; Its Restora subsidiary will present at BIO-Europe.
Immuneering Appoints Accomplished Commercial Leader Grant Bogle to Board of Directors
- Former TESARO Chief Commercial Officer and Nuvalent board member brings extensive experience in oncology product launches and commercial strategy - - Led commercialization of ZEJULA for ovarian cancer at TESARO and held senior commercial leadership roles at Millennium Pharmaceuticals and McKesson Specialty Health - NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced the appointment of Grant Bogle to its Board of Directors, effective November 09, 2026. “Grant brings an exceptional combination of oncology commercialization expertise, strategic leadership and operational experience to Immuneering at a pivotal time in our development,” said Ben Zeskind, Ph.D...
BridgeBio to Participate in November and December Investor Conferences
PALO ALTO, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences:
Braveheart Bio to Participate in the Jefferies Global Healthcare Conference in London
SAN FRANCISCO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases, today announced that the Company will participate in the Jefferies Global Healthcare Conference in London, being held November 16-19, 2026. Management will participate in a fireside chat on Wednesday, November 18, 2026, at 1:30 p.m. GMT / 8:30 a.m. ET...
Rekor Systems to Announce Third Quarter Fiscal 2026 Results
COLUMBIA, Md., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Rekor Systems, Inc. (NASDAQ: REKR) (“Rekor” or the “Company”), which builds trusted-data, privacy, and security solutions for real-world video and sensor networks, today announced that it will release its financial results for the third quarter of 2026 on Thursday, November 12, 2026, after market close...
ICE to Launch Wind Futures in Expansion of Global Energy Markets
LONDON & AMSTERDAM--(BUSINESS WIRE)--Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets, and home to the largest and most liquid markets to trade energy derivatives, today announced it plans to launch wind futures on December 14, 2026, subject to completion of relevant regulatory processes, expanding ICE's energy markets into climatic variable contracts. The 15 cash-settled wind futures are ba...
Rakuten and AST SpaceMobile Establish "Rakuten AST" Joint Venture to Build D2D Satellite Communications Network in Japan
TOKYO & MIDLAND, Texas--(BUSINESS WIRE)---- $ASTS #AST--Rakuten Group, Inc. and AST SpaceMobile, Inc. (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, agreed to establish Rakuten AST, Inc. on November 6, 2026 (Japan Standard Time)*1. The joint venture is tasked with building a direct-to-device communications network in Japan using low Earth orbit (LEO) satellites to provide service to commercially available smartphones,...
Turning Point Brands Announces Third Quarter 2026 Results
LOUISVILLE, Ky.--(BUSINESS WIRE)--Turning Point Brands, Inc. (“TPB” or “the Company”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, today announced financial results for the third quarter ended September 30, 2026. Q3 2026 Financial Highlights (All results reflect comparisons to prior-year period) Total Consolidated Net Sales increased 27.0% to $151.1 million Stoker's segment...
Formation Securities Notifies SEC of Intent to Operate First Tokenized Securities Venue on Solana
Venue combines self-custody and around-the-clock trading with the same voting, dividend and other rights as traditional U.S.-listed shares Designed to work with public companies under the conditions of the SEC's Innovation Exemption NEW YORK, Nov. 9, 2026 /PRNewswire/ -- Formation Securities LLC today notified the U.S. Securities and Exchange Commission that it intends to operate a tokenized securities venue (TSV) on Solana, a public, permissionless blockchain. Formation Securities, a business licensing trading technology from Orca, intends to operate under the SEC's Innovation Exemption...
Nevada Sunrise Completes Ground Gravity Survey at the Fivemile Gold Project, Cortez Mining District, Nevada
Vancouver, British Columbia--(Newsfile Corp. - November 9, 2026) - Nevada Sunrise Metals Corporation (TSXV: NEV) (OTC Pink: NVSGF) ("Nevada Sunrise" or the "Company") is pleased to announce the completion of a ground gravity survey program (the "Survey") at the Fivemile Gold Project ("Fivemile", or the "Project"), located within the Battle Mountain-Eureka-Cortez gold trend in Lander County, Nevada. The Company also wishes to announce the expansion of the Project area to 332 claims to a total area of approximately 6,838 acres (2,768 hectares)...
AbraSilver Intersects 75 Metres of 2.44 g/t Gold and 106 g/t Silver at Oculto; 253 Metres of 0.54 g/t Gold at Oculto East
Drilling Confirms High-Grade Mineralization Within the Planned Oculto Pit and Extends Broad Oxide Gold Zone East Towards Oculto East Toronto, Ontario--(Newsfile Corp. - November 9, 2026) - AbraSilver Resource Corp. (TSX: ABRA) (OTCQX: ABBRF) ("AbraSilver" or the "Company") is pleased to report assay results from two additional diamond drill holes, DDH-26-064 and DDH-26-063A, completed at the Oculto deposit as part of the ongoing Phase VI exploration program at its wholly-owned Diablillos project in Argentina (the "Project"). DDH-26-064 was drilled as an infill hole within the planned Oculto open pit and intersected 75.0 m grading 2.44 g/t gold and 106 g/t silver in oxides...
Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London
WARSAW, Ind., Nov. 9, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will be presenting at the Annual Jefferies Global Healthcare Conference in London on Thursday, November 19 at 1:00 p.m...
Revival Gold Further Consolidates Land Position at Mercur Gold Project, Utah
Toronto, Ontario--(Newsfile Corp. - November 9, 2026) - Revival Gold Inc. (TSXV: RVG) (OTCQX: RVLGF) ("Revival Gold" or the "Company") is pleased to announce the exercise of previously disclosed options (the "Options") to acquire private property interests at its Mercur Gold Project ("Mercur" or the "Project") in Utah. The Company has also further consolidated its land position by securing additional peripheral mineral interests through a Utah State auction process...
Soluna Announces Date of Third Quarter 2026 Earnings Call
Company to host conference call on November 16, 2026 at 5:00 PM ET ALBANY, N.Y., Nov. 9, 2026 /PRNewswire/ -- Soluna Holdings, Inc. ("Soluna") (Nasdaq: SLNH), a developer of green data centers for intensive computing applications, including AI and Bitcoin mining, today announced it will release its third quarter 2026 financial results on Monday, November 16, 2026, and host a conference call and webcast beginning at 5:00 PM ET...
ADC Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Updates
Third quarter 2026 net product revenue of $21 million; cash and cash equivalents of $189.2 million as of September 30, 2026 Strategic financial restructuring strengthens balance sheet, extending expected cash runway into 2029 Abstracts accepted for presentation at ASH 2026, highlighting ZYNLONTA's potential across multiple B-cell malignancies Tanabe's marketing authorization application filing and sublicensing in Japan support anticipated regulatory and commercial milestones for ADC Therapeutics LAUSANNE, Switzerland, Nov. 9, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT) today reported full financial results for the third quarter ended September 30, 2026, and provided recent operational updates. "During the third quarter, we made meaningful progress toward strengthening ADC Therapeutics' balance sheet and increasing strategic optionality while advancing clinical opportunities for ZYNLONTA," said Ameet Mallik, Chief Executive Officer of ADC Therapeutics...
Bicara Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Achieved substantial enrollment in FORTIFI-HN01 pivotal trial in 1L R/M HPV-negative HNSCC; topline results from interim analysis expected in mid-2027 Enrolling FORTIFI-FLEX alternate dosing study; expect to have data by the time of potential U.S. approval in 1L R/M HPV-negative HNSCC Company to host conference call and webcast today, November 9, 2026 at 8:30 a.m. ET BOSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced financial results for the third quarter ended September 30, 2026 and provided a business update...
Greenland Mines Ltd Provides Early Warning Disclosure Regarding AnorTech Inc.
CHARLOTTE, N.C., Nov. 09, 2026 (GLOBE NEWSWIRE) -- via IBN — Greenland Mines Ltd (“Greenland Mines” or the “Company”) (Nasdaq: GRML; FSE: HK6), a Greenland-focused critical-minerals developer, today announced that it has increased its ownership interest in AnorTech Inc. (TSXV: ANOR) (“AnorTech” or the “Issuer”) to approximately 19.9% following the exercise of its option to acquire additional common shares of AnorTech...
Goodyear Provides Corporate Update
Director Roger Wood Appointed Interim CEO, Board Initiates CEO Search Process Board Provides Update on Special Committee and Ongoing Strategic Assessment AKRON, Ohio, Nov. 9, 2026 /PRNewswire/ -- The Goodyear Tire & Rubber Company (NASDAQ: GT) today announced that Roger Wood, a current member of the company's board of directors, has been appointed interim chief executive officer. Wood will lead the company while the board conducts a search for a permanent successor with a leading executive search firm...
CervoMed Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
Presentation and publication of clinical and biomarker data, regulatory developments, and 100mg BID dosing regimen support advancement of the neflamapimod clinical development program in dementia with Lewy bodies Rapidly advancing neflamapimod for the treatment of nonfluent variant primary progressive aphasia; 24-week biomarker data selected for presentation at the 19 th Annual Clinical Trials on Alzheimer's Disease Conference (CTAD 2026) BOSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today reported financial results for the third quarter ended September 30, 2026, and provided corporate updates. “The Company believes that the neflamapimod clinical development program has been significantly de-risked through the presentation and publication of compelling, supportive datasets throughout this year and the ability to advance the 100mg BID dosing regimen, strengthening its position as a potential therapeutic for dementia with Lewy bodies and other devastating neurodegenerative disorders,” stated John Alam, MD, Chief Executive Officer of CervoMed...